However, the frequency of tumors with MLH1, MGMT, and p16INK4a hypermethylation agreed with previously published reports, indicating that the patients constituted a representative colon cancer cohort with regard to methylation profiles. The gene discussed is CDKN2A; the disease is malignant colon neoplasm.